154 related articles for article (PubMed ID: 32117713)
21. Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma.
Nojima M; Matsui T; Tamori A; Kubo S; Shirabe K; Kimura K; Shimada M; Utsunomiya T; Kondo Y; Iio E; Naito Y; Ochiya T; Tanaka Y
Mol Cancer; 2016 Apr; 15(1):31. PubMed ID: 27137948
[TBL] [Abstract][Full Text] [Related]
22. Mining featured biomarkers associated with vascular invasion in HCC by bioinformatics analysis with TCGA RNA sequencing data.
Zhang R; Ye J; Huang H; Du X
Biomed Pharmacother; 2019 Oct; 118():109274. PubMed ID: 31545220
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
[TBL] [Abstract][Full Text] [Related]
24. HOTAIR, a long non-coding RNA driver of malignancy whose expression is activated by FOXC1, negatively regulates miRNA-1 in hepatocellular carcinoma.
Su DN; Wu SP; Chen HT; He JH
Oncol Lett; 2016 Nov; 12(5):4061-4067. PubMed ID: 27895772
[TBL] [Abstract][Full Text] [Related]
25. Identification of novel biomarkers for hepatocellular carcinoma using transcriptome analysis.
Xia Q; Li Z; Zheng J; Zhang X; Di Y; Ding J; Yu D; Yan L; Shen L; Yan D; Jia N; Chen W; Feng Y; Wang J
J Cell Physiol; 2019 Apr; 234(4):4851-4863. PubMed ID: 30272824
[TBL] [Abstract][Full Text] [Related]
26. Identification of crucial genes based on expression profiles of hepatocellular carcinomas by bioinformatics analysis.
Liu ZK; Zhang RY; Yong YL; Zhang ZY; Li C; Chen ZN; Bian H
PeerJ; 2019; 7():e7436. PubMed ID: 31410310
[TBL] [Abstract][Full Text] [Related]
27. Detection of canonical A-to-G editing events at 3' UTRs and microRNA target sites in human lungs using next-generation sequencing.
Soundararajan R; Stearns TM; Griswold AL; Mehta A; Czachor A; Fukumoto J; Lockey RF; King BL; Kolliputi N
Oncotarget; 2015 Nov; 6(34):35726-36. PubMed ID: 26486088
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Characterization of the RNA Editomes in Cancer Development and Progression.
Luo H; Fang S; Sun L; Liu Z; Zhao Y
Front Genet; 2017; 8():230. PubMed ID: 29387082
[TBL] [Abstract][Full Text] [Related]
29. Deep sequencing and comprehensive expression analysis identifies several molecules potentially related to human poorly differentiated hepatocellular carcinoma.
Shao P; Sun D; Wang L; Fan R; Gao Z
FEBS Open Bio; 2017 Nov; 7(11):1696-1706. PubMed ID: 29123978
[TBL] [Abstract][Full Text] [Related]
30. Metabolic Pathways Enhancement Confers Poor Prognosis in p53 Exon Mutant Hepatocellular Carcinoma.
Chen PM; Li JR; Liu CC; Tang FY; Chiang EI
Cancer Inform; 2020; 19():1176935119899913. PubMed ID: 31933519
[TBL] [Abstract][Full Text] [Related]
31. Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma.
Liao H; Liao M; Xu L; Yan X; Ren B; Zhu Z; Yuan K; Zeng Y
EBioMedicine; 2019 Mar; 41():310-319. PubMed ID: 30665854
[TBL] [Abstract][Full Text] [Related]
32. Integrated analysis of competing endogenous RNA network revealing potential prognostic biomarkers of hepatocellular carcinoma.
Liao X; Wang X; Huang K; Han C; Deng J; Yu T; Yang C; Huang R; Liu X; Yu L; Zhu G; Su H; Qin W; Zeng X; Han B; Han Q; Liu Z; Zhou X; Gong Y; Liu Z; Huang J; Winkler CA; O'Brien SJ; Ye X; Peng T
J Cancer; 2019; 10(14):3267-3283. PubMed ID: 31289599
[No Abstract] [Full Text] [Related]
33. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z
Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
[No Abstract] [Full Text] [Related]
34. Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets.
Zhang L; Liu X; Zhang X; Chen R
Mol Genet Genomics; 2016 Jun; 291(3):1035-51. PubMed ID: 26711644
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma.
Zhang Y; Wang S; Xiao J; Zhou H
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30705088
[TBL] [Abstract][Full Text] [Related]
36. Genomic Positional Dissection of RNA Editomes in Tumor and Normal Samples.
Chigaev M; Yu H; Samuels DC; Sheng Q; Oyebamiji O; Ness S; Yue W; Zhao YY; Guo Y
Front Genet; 2019; 10():211. PubMed ID: 30949194
[TBL] [Abstract][Full Text] [Related]
37. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
38. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
[TBL] [Abstract][Full Text] [Related]
39. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma.
Yin F; Shu L; Liu X; Li T; Peng T; Nan Y; Li S; Zeng X; Qiu X
J Exp Clin Cancer Res; 2016 Aug; 35(1):127. PubMed ID: 27567667
[TBL] [Abstract][Full Text] [Related]
40. Investigation of RNA Editing Sites within Bound Regions of RNA-Binding Proteins.
Weirick T; Militello G; Hosen MR; John D; Moore Iv JB; Uchida S
High Throughput; 2019 Nov; 8(4):. PubMed ID: 31795425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
